About Octapharma
Octapharma’s core business is the development, production and sale of safe and effective medicines derived from human proteins in the following areas:
- Haematology (coagulation disorders)
- Immunotherapy (immune disorders)
- Intensive Care and Emergency Medicine
- Octapharma is an independent, Swiss-based company founded in 1983 by Mr. Wolfgang Marguerre.

The Group has since grown to include five state-of-the-art production plants in Austria, France, Germany, Sweden and Mexico, 54 Plasma Donation Centres in the US and in Europe as well as 45 subsidiaries and representative offices. With 5,000 employees, Octapharma currently makes sales in over 80 countries.

Turnover in 2009 broke the €1 billion mark, and we continue to grow and invest heaviliy in the future. Profits are mainly channelled into R&D and further production improvements and expansion

For more information on roles within this company please contact your Octapharma Account Manager